SOTERA HEALTH COMPANY

(SHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sotera Health to Present at the Virtualá40th Annual J.P. Morgan Healthcare Conference

01/03/2022 | 04:30pm EDT

CLEVELAND, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 7:30 am Eastern. In his presentation, Mr. Petras will provide an update on Sotera Health’s businesses. Sotera Health management, including Chief Financial Officer Scott Leffler, will participate in one-on-one meetings with investors during the conference.

Investors and the general public are invited to listen to the live webcast of Mr. Petras’ presentation by accessing the link on the Sotera Health website under the Investor Relations section: https://investors.soterahealth.com/events-and-presentations. A replay and slides for download will also be made available.

About Sotera Health:

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

INVESTOR RELATIONS CONTACTS:    
    
Sally J. Curley, IRCJenny Kobin  
Curley Global IR, LLCIR Advisory Solutions  
IR@soterahealth.com IR@soterahealth.com   
    
MEDIA CONTACT:    
    
Kristin Gibbs   
Chief Marketing Officer, Sotera Health   
kgibbs@soterahealth.com    

Source: Sotera Health Company


Primary Logo

Source: Sotera Health Services, LLC

2022 GlobeNewswire, Inc., source Press Releases

All news about SOTERA HEALTH COMPANY
05/05SOTERA HEALTH CO Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/05TRANSCRIPT : Sotera Health Company, Q1 2022 Earnings Call, May 05, 2022
CI
05/05Sotera Health Seeks M&A
CI
05/05Sotera Health Company Adjusted Earnings, Revenue Rise in Q1; Reaffirms 2022 Outlook
MT
05/05Sotera Health Reports First-Quarter 2022 Results
GL
05/05Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Posts Q1 EPS $0.22, vs. Street Est of $..
MT
05/05Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Reports Q1 Revenue $236.8M, vs. Street ..
MT
05/05Sotera Health Reports First-Quarter 2022 Results
AQ
05/05Sotera Health Company Reports Earnings Results for the First Quarter Ended March 31, 20..
CI
05/05Sotera Health Company Reaffirms Earnings Guidance for the Year 2022
CI
More news
Analyst Recommendations on SOTERA HEALTH COMPANY
More recommendations
Financials (USD)
Sales 2022 1 018 M - -
Net income 2022 174 M - -
Net Debt 2022 1 401 M - -
P/E ratio 2022 31,4x
Yield 2022 -
Capitalization 5 529 M 5 529 M -
EV / Sales 2022 6,81x
EV / Sales 2023 6,08x
Nbr of Employees 3 000
Free-Float 96,0%
Chart SOTERA HEALTH COMPANY
Duration : Period :
Sotera Health Company Technical Analysis Chart | SHC | US83601L1026 | MarketScreener
Technical analysis trends SOTERA HEALTH COMPANY
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 19,55 $
Average target price 27,50 $
Spread / Average Target 40,7%
EPS Revisions
Managers and Directors
Michael B. Petras Chief Executive Officer
Scott J. Leffler Chief Financial Officer & Treasurer
Robert G. Hauzie Chief Information Officer
Sean Laurence Cunningham Independent Director
Dave Anthony Donnini Independent Director